Roche is planning to move a new antibiotic into late-stage clinical trials after studies showed it had potential to tackle a ...

Roche is moving its novel antibiotic zosurabalpin into phase 3 testing for carbapenem-resistant Acinetobacter baumannii (CRAB), a 'superbug' that is considered an 'urgent threat' by the CDC, in what ...

An experimental antibiotic zosurabalpin to fight deadly superbug has entered the final human trials. This development could ...

A research team affiliated with UNIST has unveiled a novel extracorporeal blood purification technology that captures and ...

Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, today announced it has ...

Abstract Extracorporeal hemoadsorption for treating bacteremia has exhibited limited success due to the lack of a clear strategy for effectively ...

New research suggests that outpatients with cancer are more likely than other outpatients to have antimicrobial-resistant bacterial pathogens.